Clinical Trial Update: SBRT Combined With Nimotuzumab and Mono-chemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the combination of SBRT, nimotuzumab, and mono-chemotherapy for locally advanced pancreatic cancer; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: NOT_YET_RECRUITING